Dr. Srinivasa Rao Allu completed his Ph.D. in Organic Chemistry at Chongqing University, Chongqing, China in 2018. Dr. Allu has been on an impressive educational and research journey, spanning various countries and institutions. He has been a postdoctoral research associate at Purdue University, USA (2018–2021), the Helmholtz Center for Infection Research, Braunschweig, Germany (2021–2023), and the University of Michigan, USA (2023–Present). His research interests include the total synthesis of natural products and studies on their structure–activity relationship (SAR), the design, synthesis, discovery, and development of novel anticancer and anti-tuberculosis drugs, and synthetic methodology. Dr. Allu has authored several peer-reviewed publications. Dr. Allu has international research experience focusing on both organic chemistry and drug discovery. His work in the synthesis of natural products and the development of novel drugs for cancer and tuberculosis indicates a commitment to advancing scientific knowledge and addressing critical health challenges.
Dr. Srinivasa Rao Allu completed his Ph.D. in Organic Chemistry at Chongqing University, Chongqing, China in 2018. Dr. Allu has been on an impressive educational and research journey, spanning various countries and institutions. He has been a postdoctoral research associate at Purdue University, USA (2018–2021), the Helmholtz Center for Infection Research, Braunschweig, Germany (2021–2023), and the University of Michigan, USA (2023–Present). His research interests include the total synthesis of natural products and studies on their structure–activity relationship (SAR), the design, synthesis, discovery, and development of novel anticancer and anti-tuberculosis drugs, and synthetic methodology. Dr. Allu has authored several peer-reviewed publications. Dr. Allu has international research experience focusing on both organic chemistry and drug discovery. His work in the synthesis of natural products and the development of novel drugs for cancer and tuberculosis indicates a commitment to advancing scientific knowledge and addressing critical health challenges.